• Contact Us
  • Glossary
  • Useful Websites
  • Download Library
  • Alert Service
  • About Vernalis
  • R & Centre
  • Business Development
  • Investor Centre
  • News Centre
  •  
  • Home

News Centre

Home / News Centre / Latest Releases / 2007
PrintEmailBookmark
  • Latest Releases
  • Regulatory Announcements
  • Vernalis Group Archive
  • British Biotech Archive
  • RiboTargets Archive
  • Media Contacts

Latest Releases

  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003

If you would like to be alerted when a press release is added to this site, please register with the Alert Service.

Select a Month:
Select a Year:
Search for:
Run your search


Date Title
21/12/2007 ADDITIONAL LISTING APPLICATION + TOTAL VOTING RIGHTS
12/11/2007 Vernalis to Present at Piper Jaffray 19th Annual Healthcare Conference
30/09/2007 Endo Pharmaceuticals and Vernalis Receive Action Letter From FDA on FROVAŽ Supplemental New Drug Application
13/09/2007 Vernalis plc: Interim Results for the six months ended 30 June 2007
13/09/2007 Vernalis announces striking weight loss in Phase I study with V24343 in overweight and mildly obese volunteers
10/09/2007 FDA informs Endo and Vernalis that new target action date on FROVAŽ sNDA is Sept. 30, 2007
03/09/2007 Vernalis receives milestone payment in Hsp90 inhibitor collaboration
28/08/2007 Vernalis PLC annouces departure of board member
17/08/2007 Endo and Vernalis provide update on Frova
16/07/2007 Positive V3381 Phase IIa results
Page 1  2  3    >>
  • Privacy
  • Legal
  • Site Map